Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/22324Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Landau, Susan M | - |
| dc.contributor.author | Villemagne, Victor L | - |
| dc.date | 2019-12-20 | - |
| dc.date.accessioned | 2020-01-07T00:33:32Z | - |
| dc.date.available | 2020-01-07T00:33:32Z | - |
| dc.date.issued | 2020 | - |
| dc.identifier.citation | Neurology 2020; 94(3): 103-104 | en |
| dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/22324 | - |
| dc.language.iso | eng | - |
| dc.title | Can amyloid PET differentiate "pure" LBD from AD with or without LBD copathology? | en |
| dc.type | Journal Article | en |
| dc.identifier.journaltitle | Neurology | en |
| dc.identifier.affiliation | Helen Wills Neuroscience Institute, University of California, Berkeley | en |
| dc.identifier.affiliation | Molecular Imaging and Therapy | en |
| dc.identifier.doi | 10.1212/WNL.0000000000008812 | en |
| dc.type.content | Text | en |
| dc.identifier.pubmedid | 31862784 | - |
| dc.type.austin | Editorial | - |
| local.name.researcher | Villemagne, Victor L | |
| item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
| item.openairetype | Journal Article | - |
| item.grantfulltext | none | - |
| item.cerifentitytype | Publications | - |
| item.fulltext | No Fulltext | - |
| item.languageiso639-1 | en | - |
| crisitem.author.dept | Molecular Imaging and Therapy | - |
| Appears in Collections: | Journal articles | |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.